1. Home
  2. ABCL vs MFIC Comparison

ABCL vs MFIC Comparison

Compare ABCL & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • MFIC
  • Stock Information
  • Founded
  • ABCL 2012
  • MFIC 2004
  • Country
  • ABCL Canada
  • MFIC United States
  • Employees
  • ABCL N/A
  • MFIC N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • MFIC Finance/Investors Services
  • Sector
  • ABCL Health Care
  • MFIC Finance
  • Exchange
  • ABCL Nasdaq
  • MFIC Nasdaq
  • Market Cap
  • ABCL 1.1B
  • MFIC 1.2B
  • IPO Year
  • ABCL 2020
  • MFIC 2004
  • Fundamental
  • Price
  • ABCL $4.72
  • MFIC $12.29
  • Analyst Decision
  • ABCL Strong Buy
  • MFIC Buy
  • Analyst Count
  • ABCL 5
  • MFIC 6
  • Target Price
  • ABCL $8.00
  • MFIC $13.50
  • AVG Volume (30 Days)
  • ABCL 3.7M
  • MFIC 399.8K
  • Earning Date
  • ABCL 11-03-2025
  • MFIC 11-06-2025
  • Dividend Yield
  • ABCL N/A
  • MFIC 12.37%
  • EPS Growth
  • ABCL N/A
  • MFIC N/A
  • EPS
  • ABCL N/A
  • MFIC 1.08
  • Revenue
  • ABCL $32,875,999.00
  • MFIC $324,241,000.00
  • Revenue This Year
  • ABCL $16.99
  • MFIC $10.33
  • Revenue Next Year
  • ABCL $63.73
  • MFIC N/A
  • P/E Ratio
  • ABCL N/A
  • MFIC $11.40
  • Revenue Growth
  • ABCL N/A
  • MFIC 16.80
  • 52 Week Low
  • ABCL $1.89
  • MFIC $10.18
  • 52 Week High
  • ABCL $5.82
  • MFIC $14.74
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 58.52
  • MFIC 37.79
  • Support Level
  • ABCL $4.32
  • MFIC $12.06
  • Resistance Level
  • ABCL $4.85
  • MFIC $12.31
  • Average True Range (ATR)
  • ABCL 0.28
  • MFIC 0.21
  • MACD
  • ABCL 0.05
  • MFIC -0.09
  • Stochastic Oscillator
  • ABCL 87.25
  • MFIC 19.01

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About MFIC MidCap Financial Investment Corporation

MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.

Share on Social Networks: